Business NewsPR NewsWire • Imanis Life Sciences Launches Line of Oncolytic Vaccinia Viruses Encoding Reporter Genes From Genelux Corporation

Imanis Life Sciences Launches Line of Oncolytic Vaccinia Viruses Encoding Reporter Genes From Genelux Corporation

Imanis Life Sciences Launches Line of Oncolytic Vaccinia Viruses Encoding Reporter Genes From Genelux Corporation

ROCHESTER, Minn., Feb. 23, 2017 /PRNewswire/ -- Imanis Life Sciences announced today the launch of a new product line of oncolytic vaccinia viruses for virotherapy research. These viruses are licensed from Genelux Corporation as part of Genelux's proprietary, vaccinia virus-based...

View More : http://www.prnewswire.com/news-releases/imanis-life-sciences-launches-line-of-oncolytic-vaccinia-viruses-encoding-report...
Releted News by prnewswire
Wolf Administration Announces 'PennDOT Connects,' New Transportation-Project Approach
Fish & Richardson Announces J. Kevin Gray as New Managing Principal in Dallas, TX Office
Imanis Life Sciences Launches Line of Oncolytic Vaccinia Viruses Encoding Reporter Genes From Genelux Corporation